FDA chief Stephen Hahn said he would act quickly to finalize the vaccine. Once approved, the vaccine will be distributed in millions of doses, intended for health care workers and nursing home seniors, as part of the largest vaccination campaign in U.S. history.
A few days ago, the Director of Medicines and Food confirmed the modern findings that the vaccine’s efficacy rate stands at 94 percent after being tested on more than 30,000 people, an unprecedented figure for clinical trials.

Modern has no less than six million vaccine doses, which are enough to vaccinate three million citizens, which were produced even before FDA approval, and are awaiting distribution in the United States. The company still has an unknown number of vaccine doses intended for export to foreign countries, including Israel.